251 related articles for article (PubMed ID: 26232051)
1. Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.
Couce ML; Ramos F; Bueno MA; Díaz J; Meavilla S; Bóveda MD; Fernández-Marmiesse A; García-Cazorla A
Eur J Paediatr Neurol; 2015 Nov; 19(6):652-9. PubMed ID: 26232051
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening of maple syrup urine disease and the effect of early diagnosis.
Chen T; Lu D; Xu F; Ji W; Zhan X; Gao X; Qiu W; Zhang H; Liang L; Gu X; Han L
Clin Chim Acta; 2023 Aug; 548():117483. PubMed ID: 37421976
[TBL] [Abstract][Full Text] [Related]
4. Maple syrup urine disease in Brazil: a panorama of the last two decades.
Herber S; Schwartz IV; Nalin T; Oliveira Netto CB; Camelo Junior JS; Santos ML; Ribeiro EM; Schüler-Faccini L; Souza CF
J Pediatr (Rio J); 2015; 91(3):292-8. PubMed ID: 25512172
[TBL] [Abstract][Full Text] [Related]
5. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease.
Simon E; Fingerhut R; Baumkötter J; Konstantopoulou V; Ratschmann R; Wendel U
J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013
[TBL] [Abstract][Full Text] [Related]
6. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
[TBL] [Abstract][Full Text] [Related]
7. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland.
O'Reilly D; Crushell E; Hughes J; Ryan S; Rogers Y; Borovickova I; Mayne P; Riordan M; Awan A; Carson K; Hunter K; Lynch B; Shahwan A; Rüfenacht V; Häberle J; Treacy EP; Monavari AA; Knerr I
J Inherit Metab Dis; 2021 May; 44(3):639-655. PubMed ID: 33300147
[TBL] [Abstract][Full Text] [Related]
8. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
[TBL] [Abstract][Full Text] [Related]
9. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening may fail to identify intermediate forms of maple syrup urine disease.
Bhattacharya K; Khalili V; Wiley V; Carpenter K; Wilcken B
J Inherit Metab Dis; 2006 Aug; 29(4):586. PubMed ID: 16830261
[TBL] [Abstract][Full Text] [Related]
11. [Advances in the diagnosis and treatment of maple syrup urine disease: experience in Galicia (Spain)].
Couce Pico ML; Castiñeiras Ramos DE; Bóveda Fontán MD; Iglesias Rodríguez AJ; Cocho de Juan JA; Fraga Bermúdez JM
An Pediatr (Barc); 2007 Oct; 67(4):337-43. PubMed ID: 17949643
[TBL] [Abstract][Full Text] [Related]
12. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation of 33 patients with maple syrup urine disease.
Khalifa OA; Imtiaz F; Ramzan K; Zaki O; Gamal R; Elbaik L; Rihan S; Salam E; Abdul-Mawgoud R; Hassan M; Hassan N; Saleh E; Seoudi D; Moustafa AS
Am J Med Genet A; 2020 Nov; 182(11):2486-2500. PubMed ID: 32812330
[TBL] [Abstract][Full Text] [Related]
16. Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.
Alotaibi AZ; AlMalki RH; Al Mogren M; Sebaa R; Alanazi M; Jacob M; Alodaib A; Alfares A; Abdel Rahman AM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891907
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
18. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
19. Intellectual outcome in children with maple syrup urine disease.
Kaplan P; Mazur A; Field M; Berlin JA; Berry GT; Heidenreich R; Yudkoff M; Segal S
J Pediatr; 1991 Jul; 119(1 Pt 1):46-50. PubMed ID: 2066858
[TBL] [Abstract][Full Text] [Related]
20. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
